Carregant...
Systemic Treatment for Advanced Hepatocellular Carcinoma
BACKGROUND: Patients with advanced hepatocellular carcinoma (HCC) have a poor prognosis. First-line sorafenib has been the standard of care for a decade, but the treatment landscape is expanding. This review provides a practical overview of current and future systemic treatment options for advanced...
Guardat en:
| Publicat a: | Liver Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6873089/ https://ncbi.nlm.nih.gov/pubmed/31768344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496439 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|